Company Data
Inhibikase Therapeutics Inc.
Ticker
IKT
Current Price
$2 -4.76%
Market Cap
$148.7M
Price Target
Refer to Report
Volume
109.4K
52wk Range
$1.12 - $4.2
Overview
Inhibikase Therapeutics (Nasdaq: IKT) is a clinical-stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics that modify Parkinson’s disease and drive functional reversal inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.